Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 RTS Opens New U.S. Headquarters | Contract Pharma
Breaking News

RTS Opens New U.S. Headquarters

RTS Life Science has opened new U.S. Headquarters, RTS Life Science LLC, which was formed from the integration of products and services following the acquisition of Hatch Science, a Massachusetts-based life science company.

RTS Life Science has opened new U.S. Headquarters, RTS Life Science LLC, which was formed from the integration of products and services following the acquisition of Hatch Science, a Massachusetts-based life science company.

RTS Life Science LLC, based south of Boston, is headed by Martin Schwalm, president and Larry Chin, vice president of sales, North America. RTS is now able to provide localized sales, engineering and support services to its U.S. client base of sample management, biobanking and pharmaceutical testing customers. The U.S. team will comprise approximately 20 mechanical, electrical, software, sales and support staff.

Gary Walsh, chief executive officer of RTS commented, “Our strategy is to strengthen our capabilities in the U.S., which has always represented a substantial part of our business. We now have an extended localized team and have fully integrated our US operations into the business. Our principle objective is to support our customers efficiently and locally and continue to deliver the high standards of service and attention that has become a hallmark of RTS.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters